Anecdotes From The Field
The Carlat Psychiatry Report, Volume 3, Number 1, January 2005
Tom Rusk, M.D. is Chief of Adult Psychiatry at Community Health & Counseling Services in Winterport, Maine. He shares his approach to minimizing the risk of SSRI-induced agitation.
Dr. Rusk has disclosed that he is a member of the speakers bureau of Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Astra Zeneca, and Eli Lilly.
Eight or nine years ago I had a couple of young adults become highly agitated and violent in the week after I started an SSRI (paroxetine in both cases). One beat up his girlfriend badly despite the lack of any history of violence previously.